Direkt zum Inhalt
Merck
  • Optimization of sustained release matrix tablet of metoprolol succinate using central composite design.

Optimization of sustained release matrix tablet of metoprolol succinate using central composite design.

Pakistan journal of pharmaceutical sciences (2013-09-17)
Li Li, Huijuan Sun, Jing Gao, Tao Jiang, Yuan Gao, Jianjun Zhang
ZUSAMMENFASSUNG

The present study was performed to optimize the formulation of metoprolol succinate (MS) sustained release tablets using hydroxypropyl methylcellulose (HPMC) and sodium alginate (SA) as the matrix combination. After investigating the effects of various parameters on drug release, a 2-factor, 5-level central composite design was employed, using the amount of HPMC K4M (A) and SA (318 cP) (B) as the independent variables and the drug percentage released at 1h, 4h, 8h, 20h (Q1, Q4, Q8, Q20) as the responses. Response surfaces were established to obtain the matrix ranges and the main factors affecting four responses. In order to validate the optimization study, six confirmatory runs were performed; indicating high predictability of response surface methodology for MS sustained release tablets. Data fitting to Peppas equation indicated that the mechanism of drug release could be diffusion along with erosion. This matrix combination can be used as a good alternative to the commercially pellet technology, which was complicated, time-consuming and energy-intensive.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Natriumalginat, powder
Sigma-Aldrich
Methylzellulose, viscosity: 4,000 cP
Sigma-Aldrich
Natriumalginat
Sigma-Aldrich
(Hydroxypropyl)methylcellulose, viscosity 2,600-5,600 cP, 2 % in H2O(20 °C)(lit.)
Sigma-Aldrich
Methylzellulose, viscosity: 15 cP, BioReagent, suitable for cell culture
Sigma-Aldrich
Natriumalginat aus Braunalgen, Medium viscosity
Sigma-Aldrich
Natriumalginat aus Braunalgen, low viscosity
Sigma-Aldrich
Natriumalginat aus Braunalgen, BioReagent, suitable for immobilization of micro-organisms
Sigma-Aldrich
Methylzellulose, viscosity: 1,500 cP
Sigma-Aldrich
(Hydroxypropyl)methylcellulose
Sigma-Aldrich
(Hydroxypropyl)methylcellulose, average Mn ~10,000
Sigma-Aldrich
Methylzellulose, viscosity: 15 cP
Sigma-Aldrich
(Hydroxypropyl)methylcellulose, viscosity 40-60 cP, 2 % in H2O(20 °C)(lit.)
Sigma-Aldrich
(Hydroxypropyl)methylcellulose, viscosity 80-120 cP, 2 % in H2O(20 °C)(lit.)
Sigma-Aldrich
Alginsäure aus Braunalgen, powder
Sigma-Aldrich
(Hydroxypropyl)methylcellulose, average Mn ~86,000
Sigma-Aldrich
Methylzellulose, viscosity: 25 cP
Sigma-Aldrich
(Hydroxypropyl)methylcellulose, average Mn ~120,000
Sigma-Aldrich
(±)-Metoprolol, ≥98% (titration), powder
Sigma-Aldrich
(Hydroxypropyl)methylcellulose, average Mn ~90,000
Sigma-Aldrich
Calciumalginat aus Braunalgen
Supelco
Metoprolol tartrate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Methocel® A15 LV, 27.5-31.5% methoxyl basis
Sigma-Aldrich
Hypromellose, meets USP testing specifications
Sigma-Aldrich
Methylzellulose, 27.5-31.5% (Methoxyl content), viscosity: 400 cP
Sigma-Aldrich
Methocel® A4M, viscosity 3000-5500 mPa.s, 2 % in H2O(20 °C)
Sigma-Aldrich
Methocel® MC, medium viscosity, Methoxyl content 27.5-31.5 %
Sigma-Aldrich
Methylzellulose, meets USP testing specifications, 26.0-33.0% (methoxyl group, on Dry Basis), viscosity: 400 cP
Supelco
Metoprolol-Tartrat, Pharmaceutical Secondary Standard; Certified Reference Material
Metoprolol -tartrat, European Pharmacopoeia (EP) Reference Standard